NCT05400330View on ClinicalTrials.gov

Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions

Alzheimer Disease

Interventions

BIOLOGICAL

LX1001

Gene therapy

Trial Locations (2)

27708

Duke University, Durham

32806

PPD- Orlando Research Unit, Orlando

Sponsors

Lead Sponsor

Lexeo Therapeutics

All Listed Sponsors

lead

Lexeo Therapeutics

INDUSTRY